Alain R Baulard

11PUBLICATIONS
79CO-AUTHORS
PharmacogenomicsMedical bacteriologyMicrobial geneticsMedical devicesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 13, 2026
In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis.

|Apr 07, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosis.

Zainab Edoo, Camille Grosse, Thomas Maitre

|Oct 03, 2025
Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification.

Janïs Laudouze, Tatyana I Rokitskaya, Akira Abolet

|Dec 01, 2023
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis.

Sushil Pandey, Catherine Vilchèze, Jim Werngren

|May 04, 2022
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis.

Marion Flipo, Rosangela Frita, Marilyne Bourotte

|Apr 23, 2022
On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9-10 December 2021.

Kevin Antraygues, Nina Compagne, Francesca Ruggieri

Pageof 2

Frequent Collaborators

6 joint publications

Priscille Brodin

3 joint publications

Vincent Delorme

3 joint publications

René Wintjens

3 joint publications

Benoit Déprez